The Boehringer Ingelheim Foundation cordially invites you to a public discussion via livestream with the 2020 Heinrich Wieland laureate Craig M. Crews from Yale University in New Haven, CT, USA.
Professor Craig M. Crews is a pioneer in the field of controlled protein degradation. He conceived and demonstrated proof-of-concept of an entirely new approach to control protein levels in cells: the so-called PROTAC (PROteolysis TArgeting Chimera) technology. Based on this technology, Professor Crews founded the start-up Arvinas, which is currently conducting first clinical trials of new treatments for metastatic prostate and breast cancer.
The virtual event Starting up science: From lab to therapy will take place on Monday, 2 November 2020, from 4:00 p.m. to 5:00 p.m. (CET) as part of Berlin Science Week.
At the event, Professor Crews will meet with Professor Christian Hackenberger in Berlin and Professor Andrea Tüttenberg in Mainz to discuss how ideas spawned by curiosity-driven research can pave the way for new therapeutic approaches and how science start-ups can succeed in the US and in Germany. At the end of the event, we will invite the audience to participate in the discussion and share their own experiences.
You can join the livestream and discussion without a need to register in advance. For more information, please visit www.heinrich-wieland-prize-2020.de
The scientific symposium and personal presentation of the award to Professor Crews have been postponed until 2021 due to the COVID-19 pandemic. Details on the rescheduled event will be published on www.heinrich-wieland-prize.de toward the end of this year.